186.11
price up icon0.26%   0.49
 
loading

Abbvie Inc (ABBV) 最新ニュース

pulisher
11:46 AM

AbbVie Inc. (ABBV) and Chicago Cubs Launch “Striking Out Cancer” Campaign - Insider Monkey

11:46 AM
pulisher
02:03 AM

AbbVie announces multi-year partnership with the Chicago Cubs - TipRanks

02:03 AM
pulisher
May 30, 2025

AbbVie (ABBV) Gains As Market Dips: What You Should Know - Nasdaq

May 30, 2025
pulisher
May 30, 2025

Final Trades: JPMorgan, Meta, Abbvie and Gap - CNBC

May 30, 2025
pulisher
May 30, 2025

AbbVie Partners with Chicago Cubs on "Striking Out Cancer" | ABB - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Class Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV)June 3, 2025 Deadline to Join – Contact Levi & Korsinsky - TradingView

May 30, 2025
pulisher
May 30, 2025

AbbVie’s ADC win shows how pharma can break through in solid tumors - Pharma Voice

May 30, 2025
pulisher
May 30, 2025

AbbVie (ABBV) Stock Dips in Morning Trade: What Key Numbers Reveal - Daily Chhattisgarh News

May 30, 2025
pulisher
May 30, 2025

Analyst recommendations: AbbVie, Emerson Electric, Marriott International, Zscaler, and Monster Beverage… - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

AbbVie (ABBV) Partners with Chicago Cubs for Cancer Awareness In - GuruFocus

May 30, 2025
pulisher
May 30, 2025

AbbVie (ABBV) Partners with Chicago Cubs for Cancer Awareness Initiative | ABBV Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

AbbVie Partners with Chicago Cubs on "Striking Out Cancer" - PR Newswire

May 30, 2025
pulisher
May 30, 2025

How Is AbbVie's Stock Performance Compared To Other Pharmaceuticals Stocks? - Barchart.com

May 30, 2025
pulisher
May 30, 2025

Berenberg Adjusts Price Target on AbbVie to $170 From $195, Maintains Hold Rating - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

The Zacks Analyst Blog Highlights Berkshire Hathaway, AbbVie, Intuitive Surgical, Hamilton Beach Brands and AXIL Brands - Yahoo Finance

May 30, 2025
pulisher
May 30, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Cerevel Therapeutics Holdings, Inc. LawsuitABBV - marketscreener.com

May 30, 2025
pulisher
May 29, 2025

Top Research Reports for Berkshire Hathaway, AbbVie & Intuitive Surgical - MSN

May 29, 2025
pulisher
May 29, 2025

Contact The Gross Law Firm by June 3, 2025 Deadline to Join Class Action Against Cerevel Therapeutics Holdings, Inc.(ABBV) - TradingView

May 29, 2025
pulisher
May 29, 2025

AbbVie Stock Down Around 13% in 3 Months: Time to Buy the Dip? - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

AbbVie: Fairly Valued, But Lacking A Spark - Seeking Alpha

May 29, 2025
pulisher
May 29, 2025

Cancer Therapeutics Market Is Booming So Rapidly 2025-2032 - openPR.com

May 29, 2025
pulisher
May 29, 2025

Class Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV) Seeking Recovery for InvestorsContact The Gross Law Firm - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Drug Device Combination Products Market Analysis Report 2025-2030: Discover the Latest Advances and Opportunities - GlobeNewswire Inc.

May 29, 2025
pulisher
May 29, 2025

AbbVie Inc. (ABBV)’s Pipeline Advances with Temab-A and ABBV-706, Shares Flat - Yahoo Finance

May 29, 2025
pulisher
May 28, 2025

Sarah Cannon Research Institute Announces Strategic Alliance with AbbVie to Advance Novel Cancer Therapies - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

CERE DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - GlobeNewswire Inc.

May 28, 2025
pulisher
May 28, 2025

AbbVie (NYSE:ABBV) Showcases Promising Phase 1 ADC Results For Advanced Cancers - Yahoo Finance

May 28, 2025
pulisher
May 28, 2025

Bearish Sentiment and Increased Put Activity for AbbVie (ABBV) | - GuruFocus

May 28, 2025
pulisher
May 28, 2025

AbbVie put volume heavy and directionally bearish - TipRanks

May 28, 2025
pulisher
May 28, 2025

Sarah Cannon Research Institute Announces Strategic Alliance With AbbVie to Advance Novel Cancer Therapies - BioSpace

May 28, 2025
pulisher
May 28, 2025

Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? - sharewise

May 28, 2025
pulisher
May 28, 2025

Targeted Drug Delivery Research Business Analysis Report 2024-2030 with Focus on 30+ Key Players Such as AbbVie, Amgen, AstraZeneca, Becton Dickinson and Co, & Bristol-Myers Squibb - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

AbbVie’s Allergan cuts over 200 staff after botched marketing campaign - PharmaLive

May 28, 2025
pulisher
May 27, 2025

AbbVie Inc. (ABBV) Scores Major Legal Victory as Illinois Court Shuts Down $63 Billion Allergan Shareholder Lawsuit - MSN

May 27, 2025
pulisher
May 27, 2025

AbbVie To Present Cancer Trial Data At Upcoming ASCO Event - Benzinga

May 27, 2025
pulisher
May 27, 2025

AbbVie Features New Data Across Difficult-to-Treat Solid Tumors and Blood Cancers at ASCO 2025, Highlighting Breadth and Depth of its Oncology Portfolio - Investing News Network

May 27, 2025
pulisher
May 27, 2025

AbbVie Features New Data Across Difficult-to-Treat Solid Tumors and Blood Cancers at ASCO 2025, Highlighting Breadth and Depth of its Oncology Portfolio | ABBV Stock News - GuruFocus

May 27, 2025
pulisher
May 26, 2025

Tissue Engineering Market Generated Opportunities, Future - openPR.com

May 26, 2025
pulisher
May 26, 2025

Prurigo Nodularis Market - GlobeNewswire Inc.

May 26, 2025
pulisher
May 26, 2025

AbbVie’s SWOT analysis: biopharma giant faces pipeline challenges amid stock growth - Investing.com

May 26, 2025
pulisher
May 26, 2025

Precision immunology Market Growth in Future Scope 2025-2032 | - openPR.com

May 26, 2025
pulisher
May 26, 2025

Immunomodulatory Drugs Market in 2025 Detailed Study Analysis | - openPR.com

May 26, 2025
pulisher
May 26, 2025

Rising Leaders 2025: Pedro Valencia’s ADC Vision At AbbVie - insights.citeline.com

May 26, 2025
pulisher
May 25, 2025

CERE DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - GlobeNewswire Inc.

May 25, 2025
pulisher
May 24, 2025

AbbVie Secures FDA Nod for New ADC Drug Emrelis in Lung Cancer - MSN

May 24, 2025
pulisher
May 23, 2025

Key Drivers Behind AbbVie’s (ABBV) Performance - Insider Monkey

May 23, 2025
pulisher
May 23, 2025

Levi & Korsinsky Notifies Cerevel Therapeutics Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineABBV - marketscreener.com

May 23, 2025
pulisher
May 22, 2025

AbbVie (NYSE:ABBV) Faces Legal Scrutiny Over Merger With Cerevel - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

AbbVie and U of T Mississauga's SpinUp Announce Neuropeutics Inc as First AbbVie Biotech Innovators Award Recipient - Investing News Network

May 22, 2025
pulisher
May 22, 2025

AbbVie Secures Legal Victory Over Allergan Share Dispute - USA Herald

May 22, 2025
pulisher
May 22, 2025

Interleukin Inhibitors Market Detailed In New Research Report - openPR.com

May 22, 2025
pulisher
May 22, 2025

AbbVie (ABBV) has a Stable and Highly Profitable Business Model - Insider Monkey

May 22, 2025
drug_manufacturers_general JNJ
$155.21
price up icon 1.06%
drug_manufacturers_general NVS
$115.76
price up icon 2.82%
drug_manufacturers_general NVO
$71.50
price up icon 2.94%
drug_manufacturers_general MRK
$76.84
price up icon 0.58%
drug_manufacturers_general GSK
$41.03
price up icon 2.58%
大文字化:     |  ボリューム (24 時間):